
Pregabalin (75mg) + Etoricoxib (60mg)
Active composition
+1 more active ingredient
Pregabalin binds to the alpha-2-delta subunit of voltage-gated calcium channels, inhibiting excitatory neurotransmitter release and reducing neuronal excitability.
Etoricoxib selectively inhibits COX-2, reducing the production of pro-inflammatory prostaglandins.
Medical applications
Etowin PG 75mg/60mg Tablet is a combination medication containing Pregabalin 75mg and Etoricoxib 60mg, designed to provide effective relief from neuropathic pain and inflammation. Pregabalin is an anticonvulsant that works by calming overactive nerves, thereby reducing nerve pain, while Etoricoxib is a selective COX-2 inhibitor that helps alleviate pain and inflammation associated with conditions such as osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. This dual-action formulation is particularly beneficial for patients experiencing chronic pain with an inflammatory component, offering both analgesic and anti-inflammatory effects. Etowin PG is typically prescribed for managing diabetic neuropathy, post-herpetic neuralgia, and musculoskeletal pain where inflammation plays a significant role. The tablet should be taken as directed by a healthcare professional, usually once daily, with or without food. Patients should inform their doctor about any history of cardiovascular disease, gastrointestinal issues, or kidney problems before starting this medication. Common side effects may include dizziness, drowsiness, gastrointestinal discomfort, or mild swelling. Etowin PG 75mg/60mg Tablet should be used under medical supervision to ensure optimal efficacy and safety.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Information regarding the use of Etowin PG 75mg/60mg Tablet during pregnancy is not available. Please consult your doctor.
High Risk
Information regarding the use of Etowin PG 75mg/60mg Tablet during breastfeeding is not available. Please consult your doctor.
Medical Advice
There is limited information available on the use of Etowin PG 75mg/60mg Tablet in patients with kidney disease. Please consult your doctor.
Exercise Caution
It is not known whether Etowin PG 75mg/60mg Tablet alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Consult Doctor
There is limited information available on the use of Etowin PG 75mg/60mg Tablet in patients with liver disease. Please consult your doctor.
Regular Checkup
0 reviews for Etowin PG 75mg/60mg Tablet

Pregabalin (75mg) + Etoricoxib (60mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+1 more active ingredient
Pregabalin binds to the alpha-2-delta subunit of voltage-gated calcium channels, inhibiting excitatory neurotransmitter release and reducing neuronal excitability.
Etoricoxib selectively inhibits COX-2, reducing the production of pro-inflammatory prostaglandins.
Medical applications
Etowin PG 75mg/60mg Tablet is a combination medication containing Pregabalin 75mg and Etoricoxib 60mg, designed to provide effective relief from neuropathic pain and inflammation. Pregabalin is an anticonvulsant that works by calming overactive nerves, thereby reducing nerve pain, while Etoricoxib is a selective COX-2 inhibitor that helps alleviate pain and inflammation associated with conditions such as osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. This dual-action formulation is particularly beneficial for patients experiencing chronic pain with an inflammatory component, offering both analgesic and anti-inflammatory effects. Etowin PG is typically prescribed for managing diabetic neuropathy, post-herpetic neuralgia, and musculoskeletal pain where inflammation plays a significant role. The tablet should be taken as directed by a healthcare professional, usually once daily, with or without food. Patients should inform their doctor about any history of cardiovascular disease, gastrointestinal issues, or kidney problems before starting this medication. Common side effects may include dizziness, drowsiness, gastrointestinal discomfort, or mild swelling. Etowin PG 75mg/60mg Tablet should be used under medical supervision to ensure optimal efficacy and safety.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Information regarding the use of Etowin PG 75mg/60mg Tablet during pregnancy is not available. Please consult your doctor.
High Risk
Information regarding the use of Etowin PG 75mg/60mg Tablet during breastfeeding is not available. Please consult your doctor.
Medical Advice
There is limited information available on the use of Etowin PG 75mg/60mg Tablet in patients with kidney disease. Please consult your doctor.
Exercise Caution
It is not known whether Etowin PG 75mg/60mg Tablet alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Consult Doctor
There is limited information available on the use of Etowin PG 75mg/60mg Tablet in patients with liver disease. Please consult your doctor.
Regular Checkup
0 reviews for Etowin PG 75mg/60mg Tablet











